📊 *Post-Market Snapshot (Feb 13, 2025)* 📈 *Indices:* 🔹 Nifty 50: 23,031 (-0.06%) | 🔹 Sensex: 76,138 (-0.04%) | 🔹 India VIX: 14.96 (+0.40%) 📌 *Sector Performance:* ✅ Gainers: Pharma (+1.35%), Healthcare (+1.24%), Metal (+0.8%) ❌ Losers: IT (-1.0%), PSU Bank (-0.90%) 📌 *Stock Movers:* 🚀 Top Gainers: Finolex Cables ₹998 (+13.05%), Honasa Consumer ₹230 (+12.74%) 📉 Top Loser: Natco Pharma ₹975 (-20.0%) 📰 *Key Updates:* 🔹 PNGJL ₹680.80 🔼 +9.99% | Q3 profit up 49% YoY to ₹86 crore, revenue up 23.5%. Opened 9 new showrooms in 9 days; store count at 48, targeting 53 by Q4FY25. 🔹 SHILPAMED ₹680 🔼 +2.74% | SEC-CDSCO approval for Nor-Ursodeoxycholic Acid Tablets (500 mg) for NAFLD treatment. Phase 3 trials show significant liver function improvement. 🔹 M&MFIN ₹282.60 🔼 +2.37% | To raise ₹3,000 crore via rights issue to boost Tier 1 capital and AUM growth. 🔹 NXST ₹132.64 🔼 +0.42% | ₹869.75 crore acquisition of Vega City Mall, now Bengaluru’s largest retail platform with 96% occupancy. 🔹 NATCOPHARM ₹975.05 🔻 -20.0% | Q3 net profit down 38% to ₹132.4 crore, revenue drops 37% due to 53% decline in formulation exports. 🚀 Market remains range-bound as pharma and metal stocks shine while IT and PSU banks drag.